About: http://data.cimple.eu/news-article/34cdf38eb8cf2955cf1b9af580399c44dd37da242c624ff121f27e71

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/34cdf38eb8cf2955cf1b9af580399c44dd37da242c624ff121f27e71 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Egypt said Saturday the first doses of the coronavirus vaccine developed by Anglo-Swedish pharmaceutical giant AstraZeneca would arrive on Sunday. The Egyptian authority in charge of the acquisition of pharmaceuticals announced "the arrival of the first batch of the AstraZeneca-Oxford vaccine tomorrow, Sunday January 31, 2021", without specifying the number of doses. Last week, officials said they had ordered 20 million doses, according to Egyptian media. Egypt, the Arab world's most populous country with around 100 million people, has recorded nearly 165,000 Covid-19 cases, including more than 9,200 deaths. But some health officials suggest the reported infection rate is much lower than actual figures. Cairo started vaccinating healthcare workers using China's Sinopharm jabs on January 24, the first doses of which were delivered in December. On Friday, Health Minister Hala Zayed said that 1,315 medical workers had received a first dose. Jabs will be rolled out next to the elderly and people with chronic health conditions. AstraZeneca was initially praised for the speed of its vaccine development, but is now being criticised for delays in delivery to the European Union due to production problems. Germany's Robert Koch Institute has also questioned the effectiveness of the jab among the over-65s, citing gaps in test data. mon/hha/sw/pjm
schema:headline	Egypt to receive first AstraZeneca vaccines Sunday
schema:mentions	Arab League Populous (company) Egyptians Cairo Pharmaceutical industry Robert Koch Institute Jab Egypt AstraZeneca Germany Vaccine United States China Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Hill-holder China National Pharmaceutical Group
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-01-30 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	82 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software